Clinical stage biopharmaceutical company focused on development of novel therapeutics for cancer and age-related macular degeneration.

Sectors
Healthcare
Life Sciences
First Invested
2014
Early
Company Status
IPO/Public
NASDAQ: TCON
Associated Team
Paul Walker